Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Syncona Creates Second Gene Therapy Company With £25m Financing

This article was originally published in Scrip

Executive Summary

The Wellcome Trust's investment subsidiary Syncona LLP has put £25m of series A financing into a new gene therapy company, Freeline Therapeutics, spun off from University College London (UCL) via its technology transfer arm UCL Business PLC. Freeline's initial focus will be on bleeding disorders.